Amgen beats EPS and revenue, $6.42B vs. $6.38B, raises full-year guidance

Amgen beats EPS and revenue, $6.42B vs. $6.38B, raises full-year guidance

Meg Tirrell joins ‘Closing Bell’ to report Amgen’s quarterly earnings.

as per our monitoring this Story originally appeared on

*CNBC Television*

Amgen beats EPS and revenue, $6.42B vs. $6.38B, raises full-year guidance

Have A Say ?

Pay A Visit : CNBC Television Story

Hi Viewer of this Story,

You may add your Story ;

Visit & Add: SocialStory

Add your News,
Views,
Consciences,
Etc.
as Story

Story starts here